Virtual Tumor Board: Targeting Residual Disease

May 13, 2025
Episode
289
Share

In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case with Dr. Mara Antonoff, Dr. Shankar Siva, and Dr. David Carbone. The case explores the role of ablative therapy for residual disease in patients with stage IV NSCLC.

Guest
Stephen Liu
Stephen Liu

MD

Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
David Carbone
David Carbone

MD, PhD

Thoracic Medical Oncologist
James Thoracic Center
Barbara J. Bonner Chair in Lung Cancer Research Ohio State University
Mara Antonoff
Mara Antonoff

PhD, MBBS

Department of Radiation Oncology
Peter MacCallum Cancer Centre
University of Melbourne
Shankar Siva
Shankar Siva

M.B.B.S., PhD

Associate Professor, Radiation Oncologist,
Peter MacCallum Cancer Centre

Other Podcast